R&D-driven medical progress, health care costs, and the future of human longevity

Ngā tūemi rite

• THE IRS2 GLY 1057 ASP VARIANT IS ASSOCIATED WITH HUMAN LONGEVITY
  mā: BARBIERI, M.
  I whakaputaina: (2010)
• Modeling the impact of COVID-19 pandemic-driven increases in alcohol consumption on health outcomes and hospitalization costs in the United States
  mā: Barbosa, C.
  I whakaputaina: (2023)
• Innovative robotic technologies and artificial intelligence in pharmacy and medicine: paving the way for the future of health care—a review
  mā: Stasevych, M.
  I whakaputaina: (2023)
• A HUMAN DEVELOPMENT INTERVENTION IN THE PHILIPPINES: EFFECT ON CHILD MORBIDITY
  mā: HILL, J.M
  I whakaputaina: (1990)
• Global Alliance International Longevity Centre. Designing the future of ageing
  I whakaputaina: (2021)